Renu Virmani Selected Research

Coronary Thrombosis

2/2007	Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications.
10/2004	The accumulation of specific types of proteoglycans in eroded plaques: a role in coronary thrombosis in the absence of rupture.
2/2004	Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?
1/2004	Short-term intravenous eptifibatide infusion combined with reduced dose recombinant tissue plasminogen activator inhibits platelet recruitment at sites of coronary artery injury.
11/2002	Increased serum homocysteine and sudden death resulting from coronary atherosclerosis with fibrous plaques.
10/2002	Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion.
4/2002	Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renu Virmani Research Topics

Disease

98	Thrombosis (Thrombus) 10/2022 - 02/2002
57	Inflammation (Inflammations) 12/2021 - 02/2002
55	Atherosclerotic Plaque (Atheroma) 10/2022 - 04/2002
46	Atherosclerosis 12/2021 - 04/2002
33	Rupture 01/2022 - 04/2002
31	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 08/2001
31	Pathologic Constriction (Stenosis) 01/2021 - 06/2002
20	Neointima 01/2020 - 02/2002
18	Myocardial Infarction 07/2021 - 10/2003
16	Hemorrhage 01/2022 - 12/2003
15	Acute Coronary Syndrome 01/2020 - 10/2003
15	Hyperplasia 11/2016 - 02/2002
14	Hypersensitivity (Allergy) 01/2018 - 01/2004
13	Necrosis 02/2018 - 12/2003
11	Hypertension (High Blood Pressure) 01/2022 - 01/2002
11	Cardiovascular Diseases (Cardiovascular Disease) 11/2019 - 10/2003
9	Ischemia 12/2018 - 02/2007
9	Infarction (Infarctions) 12/2018 - 01/2002
8	Aneurysm (Aneurysms) 02/2016 - 07/2002
7	ST Elevation Myocardial Infarction 08/2021 - 03/2013
7	Coronary Thrombosis 02/2007 - 04/2002
6	Neoplasms (Cancer) 01/2021 - 11/2002
6	Sudden Death 12/2012 - 07/2002
5	AIDS-Related Complex (ARC) 01/2021 - 05/2011
5	Coronary Disease (Coronary Heart Disease) 09/2019 - 11/2002
5	Fibrosis (Cirrhosis) 06/2014 - 01/2002
4	Vascular Calcification 01/2022 - 12/2004
4	Stroke (Strokes) 10/2019 - 01/2016
4	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2018 - 10/2003
4	Aortic Valve Stenosis (Aortic Stenosis) 01/2018 - 01/2016
4	Vascular Diseases (Vascular Disease) 01/2017 - 02/2004
3	COVID-19 01/2022 - 01/2021
3	Calcinosis 01/2018 - 08/2015
3	Intracranial Embolism 01/2018 - 10/2012
3	Diabetes Mellitus 01/2017 - 08/2014
3	Vascular Remodeling 09/2016 - 07/2007
3	Disease Progression 08/2015 - 09/2008
3	Coronary Occlusion 01/2012 - 12/2006
2	Arterial calcification of infancy 01/2022 - 09/2018
2	Atrial Fibrillation 11/2018 - 05/2002

Drug/Important Bio-Agent (IBA)

36	LipidsIBA 05/2020 - 01/2002
26	Phenobarbital (Luminal)FDA Link 01/2021 - 02/2002
25	PolymersIBA 01/2022 - 11/2002
24	MetalsIBA 03/2019 - 10/2003
22	FibrinIBA 01/2021 - 02/2002
20	Sirolimus (Rapamycin)FDA Link 08/2014 - 10/2003
18	CholesterolIBA 01/2022 - 01/2002
17	Pharmaceutical PreparationsIBA 01/2020 - 01/2005
14	Everolimus FDA Link 06/2020 - 10/2002
14	Paclitaxel (Taxol)FDA LinkGeneric 02/2018 - 07/2005
11	Proteoglycans (Proteoglycan)IBA 01/2021 - 02/2002
11	CollagenIBA 01/2021 - 02/2002
10	Biomarkers (Surrogate Marker)IBA 12/2017 - 11/2006
9	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022 - 12/2005
8	CalciumIBA 01/2022 - 01/2002
6	omega-Chloroacetophenone (Mace)IBA 07/2021 - 10/2004
5	CytokinesIBA 12/2021 - 12/2010
5	Annexin A5IBA 12/2018 - 12/2003
5	Apolipoproteins E (ApoE)IBA 01/2016 - 09/2006
5	zotarolimusIBA 01/2012 - 06/2005
4	Proteins (Proteins, Gene)FDA Link 12/2021 - 12/2003
4	IronIBA 09/2019 - 12/2003
4	Biological ProductsIBA 09/2016 - 11/2002
4	ApolipoproteinsIBA 01/2016 - 09/2006
4	Hyaluronic Acid (Hyaluronan)IBA 08/2015 - 10/2002
3	Fluorocarbon PolymersIBA 01/2022 - 09/2017
3	LigandsIBA 12/2021 - 07/2004
3	Phosphotransferases (Kinase)IBA 12/2021 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 02/2014
3	LeptinIBA 01/2016 - 10/2012
3	Versicans (Versican)IBA 08/2015 - 10/2002
3	C-Reactive ProteinIBA 07/2014 - 04/2002
3	Lipoproteins (Lipoprotein)IBA 06/2014 - 01/2012
3	Matrix Metalloproteinases (MMPs)IBA 06/2013 - 09/2009
3	Phospholipids (Phosphatides)FDA LinkGeneric 12/2012 - 10/2005
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2010 - 02/2007
3	HDL CholesterolIBA 02/2010 - 01/2002
3	Metalloproteases (Metalloproteinases)IBA 09/2009 - 07/2003
3	DecorinIBA 12/2004 - 10/2002
3	Collagen Type I (Type I Collagen)IBA 12/2004 - 10/2002
2	oxidized low density lipoproteinIBA 12/2021 - 01/2019
2	AntibodiesIBA 06/2021 - 02/2004
2	TOR Serine-Threonine KinasesIBA 01/2020 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 09/2007
2	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 12/2017 - 11/2006
2	AnticoagulantsIBA 10/2017 - 01/2015
2	AlbuminsIBA 09/2017 - 11/2002
2	MineralsIBA 01/2017 - 12/2004

Therapy/Procedure

121	Stents 10/2022 - 02/2002
45	Drug-Eluting Stents 01/2022 - 01/2004
35	Therapeutics 01/2022 - 08/2001
21	Percutaneous Coronary Intervention 10/2022 - 10/2004
6	Catheters 01/2021 - 12/2002
5	Transcatheter Aortic Valve Replacement 10/2019 - 04/2015
4	Denervation 01/2021 - 10/2013
3	Radiotherapy 01/2021 - 12/2002
3	Carotid Endarterectomy 12/2012 - 08/2006
2	Thrombectomy 01/2021 - 03/2013
2	Transplantation 01/2020 - 07/2004
2	Drug Therapy (Chemotherapy) 01/2020 - 07/2009